ACO Name and Location
JFK Population Health Company, LLC dba. JFK Health ACO, Hackensack Meridian ACO, HMH ACO
Previous Names: N/A
Corporate Address: 343 Thornall Street Edison, NJ 08818
Business Address: 98 James Street Suite 304 Edison, NJ 08820
ACO Primary Contact
| Primary Contact Name | Sheilah McCoy BSN, RN |
| Primary Contact Phone Number | 732-744-5980 |
| Primary Contact Email Address | sheilah.mccoy@hmhn.org |
Organizational Information
ACO Participants |
ACO Participant in Joint Venture (Enter Y or N) |
Allison L Faches PA |
N |
Bruce Soriano |
N |
Brunswick Internal Medicine Group, PC |
N |
Cardiovascular Consultants, PA |
N |
CGF Medical Center PA |
N |
Clarabarton Cardio Medical Association Inc. |
N |
Coastal Medical Group, PA |
N |
Community Hospital Group Inc |
N |
Dewan S. Khan M.D., P.C. |
N |
Edison Nephrology Consultants |
N |
Endocrinology T&S |
N |
Fauzia Hameed, MD, LLC |
N |
Forrayan LLC |
N |
Harry Collins, MD LLC |
N |
Healthy Life MD, LLC |
N |
Indravadan T Patel MD PA |
N |
Janardhan Bollu |
N |
Janardhan Bollu MD PA |
N |
Jasbir K.Kasuri MD PC |
N |
Jersey Heart Center LLC |
N |
JFK Medical Associates, PA |
N |
JFK Medical Group, PC |
N |
Joseph Robbins |
N |
Kespra Medical Center LLC |
N |
Ketankumar Vaidya, LLC |
N |
Kishore Ramchandani |
N |
Linden Medical Group, LLC |
N |
M.A. Sarraf, M.D., P.A. |
N |
Menlo Park Medical Group P.A. |
N |
Mid Jersey Medical Associates PA |
N |
Mohammad A. Zubair, LLC |
N |
Nandini Moray, MD PA |
N |
Neha Shah MD LLC |
N |
Oak Tree Family Practice, LLC |
N |
Oak Tree Patient Care PC |
N |
Pradip A. Shah, M.D. P.C. |
N |
Primary Care Nj Llc |
N |
Pulmonary Internists, PA |
N |
Richard Menashe |
N |
Shefali Patel |
N |
Sunil Patel |
N |
Syed Siddiq |
N |
Thomas J. Cassidy MD LLC |
N |
ACO governing body:
Member |
Member's Voting Power – Expressed as a percentage |
Membership Type |
ACO Participant Legal Business Name |
||
First Name |
Last Name |
Title/Position |
|||
Bhudev |
Sharma |
Chair |
14.29% |
ACO Participant Representative |
JFK Medical Associates |
Maria |
Flores |
MD |
14.29% |
ACO Participant Representative |
JFK Associates |
Rajesh |
Patel |
DO |
14.29% |
ACO Participant Representative |
Forrayan |
Ketankumar |
Vaidya |
MD |
14.29% |
ACO Participant Representative |
Ketan Vaidya, MD, LLC |
William |
Oser |
ACO Executive Director |
0 |
Other |
|
William |
Rossy |
MD |
14.29% |
ACO Participant Representative |
JFK Medical Associates |
Bruce |
Soriano |
MD |
14.29% |
ACO Participant Representative |
Bruce V. Soriano, MD |
Franklin |
Spirn |
MD |
0 |
Medicare Beneficiary Representative |
|
Amie |
Thornton |
CHE |
14.29% |
ACO Participant Representative |
Community Hospital Group, Inc |
Richard |
Hand |
CFO |
0 |
Other |
|
Sheilah |
McCoy |
Director of Care Coordination |
0 |
Other |
|
Key ACO Clinical and Administrative Leadership:
| ACO Executive | William Oser |
| Medical Director | Robin Winter |
| Compliance Officer | Thomas Flynn |
| Quality Assurance/Improvement Officer | Dr. Robert Bayly |
Associated Committees and Committee Leadership:
| Committee Name | Committee Leader Name and Position |
| ACO Quality Committee | Dr. Bhudev Sharma, MD Chairman |
| ACO Finance Committee | Mr. Richard Hand, CFO Chairman |
Types of ACO participants, or combinations of participants, that formed the ACO:
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2021, $0
- Performance Year 2020, $2,377,082.09
- Second Agreement Period
- Performance Year 2019, $3,661,811.05
- Performance Year 2018, $4,233,662.16
- Performance Year 2017, $0
- First Agreement Period
- Performance Year 2016, $0
- Performance Year 2015, $0
- Performance Year 2014, $0
Shared Savings Distribution
- Third Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: $0
- Proportion invested in redesigned care processes/resources: $0
- Proportion of distribution to ACO participants: $0
- Performance Year 2020
- Proportion invested in infrastructure: 50%
- Proportion invested in redesigned care processes/resources: 0
- Proportion of distribution to ACO participants: 50%
- Performance Year 2021
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 50%
- Proportion invested in redesigned care processes/resources: 0
- Proportion of distribution to ACO participants: 50%
- Performance Year 2018
- Proportion invested in infrastructure: 26%
- Proportion invested in redesigned care processes/resources: 0
- Proportion of distribution to ACO participants:
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- First Agreement Period
- Performance Year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2014
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Quality Performance Results
Quality Performance results are based on CMS Web Interface
| Measure Number | Measure Name | Rate | ACO Mean |
| Quality ID # 001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control2 | 9.43 | 12.46 |
| Quality ID # 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | 60.89 | 74.38 |
| Quality ID # 236 | Controlling High Blood Pressure | 80.38 | 74.87 |
| Quality ID # 318 | Falls: Screening for Future Fall Risk | 79.64 | 87.03 |
| Quality ID # 110 | Preventative Care and Screening: Influenza Immunization | 81.92 | 80.52 |
| Quality ID # 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | 90.91 | 80.97 |
| Quality ID # 113 | Colorectal Cancer Screening | 65.64 | 73.63 |
| Quality ID # 112 | Breast Cancer Screening | 72.06 | 75.11 |
| Quality ID # 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 89.56 | 84.24 |
| Quality ID # 370 | Depression Remission at Twelve Months | N/A | N/A |
| Quality ID # 321 | CAHPS for MIPS3 | N/A | N/A |
| Measure # 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2 | 0.1638 | 0.1540 |
| Measure # MCC1 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)2 | 35.30 | 33.99 |
Please note, the Quality ID #: 370 Depression Remission at 12 months qualitymeasure is not included in public reporting due to low sample size.
Note: For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.